SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-033796
Filing Date
2019-08-30
Accepted
2019-08-30 16:33:34
Documents
5
Period of Report
2019-08-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flgt-8k_20190830.htm 8-K 36601
2 EX-1.1 flgt-ex11_39.htm EX-1.1 213542
3 EX-5.1 flgt-ex51_14.htm EX-5.1 21410
4 GRAPHIC gezy5wfv3wu3000002.jpg GRAPHIC 6562
5 GRAPHIC gezy5wfv3wu3000001.jpg GRAPHIC 8872
  Complete submission text file 0001564590-19-033796.txt   294349
Mailing Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780
Business Address 4978 SANTA ANITA AVENUE, SUITE 205 TEMPLE CITY CA 91780 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 191069896
SIC: 8071 Services-Medical Laboratories